Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Medicine
Volume 2017, Article ID 4895736, 5 pages
https://doi.org/10.1155/2017/4895736
Case Report

Drug Induced Pneumonitis Secondary to Treatment with Paritaprevir/Ritonavir/Ombitasvir and Dasabuvir (VIEKIRA PAK®) for Chronic Hepatitis C: Case Report of an Unexpected Life-Threatening Adverse Reaction

Liver Transplant Unit, Auckland City Hospital, 2 Park Road, Grafton, Auckland 1023, New Zealand

Correspondence should be addressed to Shih Yea Sylvia Wu; moc.liamg@9201leunammi

Received 3 February 2017; Accepted 12 March 2017; Published 20 March 2017

Academic Editor: Marco Sebastiani

Copyright © 2017 Shih Yea Sylvia Wu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Shih Yea Sylvia Wu, Bridget Faire, and Edward Gane, “Drug Induced Pneumonitis Secondary to Treatment with Paritaprevir/Ritonavir/Ombitasvir and Dasabuvir (VIEKIRA PAK®) for Chronic Hepatitis C: Case Report of an Unexpected Life-Threatening Adverse Reaction,” Case Reports in Medicine, vol. 2017, Article ID 4895736, 5 pages, 2017. https://doi.org/10.1155/2017/4895736.